Microstrategy (NASDAQ:MSTR) and its CEO Michael Saylor are in large part confounding valuation experts worldwide.
The traditional method of valuing a company goes something like this. Analyze the cash flows a company will produce over its lifetime, discount them back to present day, sum them up and arrive at a fair market valuation for the company.
» Read more about: Is Michael Saylor’s Bet Crazy: Bull vs Bear »
For nearly two years, the stock market has been steadily bidding up companies like NVIDIA and Microsoft that have emerged as front-runners in the AI race. In addition to these mega-cap companies, though, there are also many smaller companies trying to fill niche spaces in the AI market.
One such company is Nebius Group (NASDAQ:NBIS),
» Read more about: Why Did NVIDIA Invest In Little-Known AI Stock? »
Headlines swirled in recent days that Mark Zuckerberg was meeting with President-Elect Donald Trump at Mar-a-Lago.
Some speculated Zuckerberg was going to “bend the knee” while others thought he was looking for an active role in the new administration.
What we haven’t seen anyone discuss yet is whatever conversation did take place in that room appears to have been received well by markets because Meta now seems to be breaking higher.
It wasn’t long ago that I highlighted Planet Labs as a stock with the potential to blast off. At the time it was sitting at $1.90 per share.
Fast forward to the present and Planet Labs has soared well above $4 per share and is now posting gains of over 100%.
Palantir (NYSE:PLTR) has been among the biggest beneficiaries of this year’s AI bull run and the more recent post-election rally. The stock started this year at just $16.58 and has since skyrocketed to over $60 per share.
The last month has been particularly dramatic when PLTR started November a little over $40 before being pushed skyward following election news that was deemed positive and a stellar Q3 earnings report.
» Read more about: Is Palantir on the Precipice of a Sharp Fall? »
Oklo (NYSE: OKLO) shares surged over 18% Monday after President-elect Donald Trump named Liberty Energy CEO Chris Wright as his pick for Energy Secretary.
For Oklo investors, the selection carries special significance – Wright currently serves on Oklo’s board of directors, potentially giving the nuclear innovation company an influential ally in Washington just as it hits its stride with commercial deployments and new acquisitions.
» Read more about: Will Trump’s Energy Secretary Pick Drive Oklo Higher? »
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services,
» Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
In B2B sales and marketing, few companies have built as powerful a toolset as the one that caught Stan Druckenmiller’s eye.
With a unique moat in its vast proprietary database, accelerating AI-driven insights, and a growing foothold in emerging markets, this SaaS firm has become a must-have resource for enterprise sales teams.
Yet while bulls can point to a host of positive attributes,
» Read more about: Brilliant Billionaire Buys Under-the-Radar Wide Moat Stock »
Bitcoin has been on a tear lately, bringing its YTD returns to over 112%. Much of this gain can be attributed to Donald Trump’s support of bitcoin and his electoral victory, which added to an already bullish period for Bitcoin.
Now, the big question is whether the benchmark cryptocurrency could cross the $100,000 mark for the first time in the near future.
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?